Detecting and Characterizing Protein Self-Assembly In Vivo by Flow Cytometry
July 17th, 2019
11.9K views
This article describes a FRET-based flow cytometry protocol to quantify protein self-assembly in both S. cerevisiae and HEK293T cells.
Overview
This article presents Distributed Amphifluoric FRET (DAmFRET), a flow cytometry-based assay designed to detect and quantify protein self-assembly in vivo at single-cell resolution. DAmFRET overcomes limitations of previous methods by providing sensitive, high-throughput, and direct readouts, regardless of protein localization or solubility, and is applicable across various model systems.
Key Study Components
Area of Science
- Protein biochemistry
- Cell biology
- Fluorescence-based assays
Background
- Protein self-assembly is fundamental to protein function and cellular compartmentalization.
- Existing methods to study self-assembly often lack sensitivity and single-cell resolution.
- Indirect readouts and low throughput hinder comprehensive analysis.
- There is a need for robust, high-throughput, and direct assays for protein self-assembly.
Purpose of Study
- To develop a sensitive, high-throughput assay for quantifying protein self-assembly in vivo.
- To enable single-cell resolution analysis of protein assembly states.
- To provide a methodology applicable across different model organisms.
Methods Used
- Transformation and culture of yeast expressing query proteins fused to fluorescent tags.
- Induction of protein expression followed by photo-conversion using UV light.
- Flow cytometry with imaging capabilities to detect FRET signals in single cells.
- Data analysis using compensation controls and calculation of AmFRET ratios.
Main Results
- DAmFRET distinguishes between monomeric and self-assembled protein states in single cells.
- Fluorescent protein alone or with non-assembling mutants shows negligible AmFRET.
- Wild-type inflammasome protein displays two populations: non-assembled and self-assembled, indicating a nucleation barrier.
- Results are consistent across yeast and mammalian cells lacking Caspase-1.
Conclusions
- DAmFRET provides a robust, sensitive, and high-throughput method for studying protein self-assembly in vivo.
- The assay enables detection of nucleation barriers and assembly propensities at single-cell resolution.
- DAmFRET can be complemented with biochemical and structural approaches for mechanistic insights.
Frequently Asked Questions
What is DAmFRET and what does it measure?
DAmFRET (Distributed Amphifluoric FRET) is a flow cytometry-based assay that quantifies protein self-assembly in vivo by measuring FRET signals at single-cell resolution.
How does DAmFRET improve upon previous methods for studying protein self-assembly?
DAmFRET offers higher sensitivity, direct readouts, high throughput, and single-cell resolution, overcoming the limitations of indirect, low-sensitivity, and population-level assays.
What are the key steps in the DAmFRET protocol?
Key steps include culturing transformed yeast, inducing protein expression, photo-converting fluorescent proteins with UV light, and analyzing FRET signals using imaging flow cytometry.
How is the AmFRET parameter calculated?
AmFRET is calculated as the ratio of the total FRET signal to the total FRET acceptor signal, distinguishing between monomeric and self-assembled protein states.
What controls are necessary for accurate DAmFRET analysis?
Controls include non-photo-converted samples for donor signal, monomeric acceptor controls, and proper compensation for fluorescence spillover during analysis.
Can DAmFRET be used in systems other than yeast?
Yes, DAmFRET is applicable across model systems, including yeast and mammalian cells, regardless of protein localization or solubility.
What are common troubleshooting tips for DAmFRET?
Optimize photo-conversion conditions, ensure cytometer has appropriate detection filters, collect sufficient unsaturated events, and set compensation correctly for accurate results.
Executive Industry Relevance
Quantitative detection of protein self-assembly in vivo is critical for de-risking early discovery targets and understanding mechanistic drivers of disease-relevant protein aggregation. DAmFRET enables high-throughput, single-cell resolution analysis of protein assembly states, supporting predictive confidence in target validation and functional characterization. This capability strengthens portfolio triage by clarifying assembly propensities and nucleation barriers across diverse biological systems.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct interrogation of protein self-assembly mechanisms in live cells.
- Supports functional target validation by distinguishing monomeric versus assembled states.
- Facilitates mechanistic de-risking through detection of nucleation barriers and assembly thresholds.
- Improves predictive confidence for advancing aggregation-prone targets.
Screening & Assay Development
- Provides standardized, quantitative single-cell readouts for assay development.
- Enables high-throughput screening of protein variants or modulators affecting assembly.
- Supports reproducibility and scalability across model systems and protein classes.
- Delivers robust data for reliable compound or genetic perturbation evaluation.
Translational & Preclinical Research
- Aligns with disease-relevant models by enabling analysis in both yeast and mammalian cells.
- Supports translational biomarker discovery by quantifying assembly states linked to pathology.
- Facilitates continuity from discovery through preclinical validation of aggregation mechanisms.
- Enables risk-adjusted advancement decisions based on mechanistic assembly profiles.
Pipeline & Workflow Integration
DAmFRET integrates into the discovery-to-preclinical continuum by providing a reusable, quantitative platform for protein assembly analysis at multiple pipeline stages.
- Discovery Biology: Supports hypothesis testing and mechanistic clarification of protein aggregation.
- Screening: Delivers assay-ready, high-throughput, and reproducible single-cell data.
- Analytics: Provides quantitative AmFRET measurements for comparative analysis of assembly states.
- Translational Research: Enables cross-system validation and biomarker alignment for aggregation-driven pathologies.
- Enterprise Reuse: Offers a standardized workflow adaptable to diverse targets and model systems.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
- Operational Value: Enhances standardization, reproducibility, and throughput for protein assembly assays.
- Strategic Value: Informs go/no-go decisions and reduces late-stage biological risk for aggregation-prone assets.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of discovery-stage programs.
Implementation Considerations
- Requires expertise in flow cytometry and fluorescence compensation analysis.
- Needs access to imaging flow cytometers with appropriate FRET detection filters.
- Demands rigorous standardization of photo-conversion and gating protocols across teams.
- Adaptable to multiple model systems but may require empirical optimization for each.
- Dependent on sufficient event collection and proper control selection for robust data.
Biopharma FAQs
Why does null hypothesis testing matter for DAmFRET-based target validation?
Null hypothesis testing in DAmFRET enables objective assessment of whether observed assembly profiles differ from random or control distributions, supporting rigorous target validation and mechanistic de-risking in early discovery.
How does independent variable isolation fit DAmFRET in the discovery pipeline?
DAmFRET allows isolation of variables such as protein concentration or mutational status, clarifying their direct impact on self-assembly and informing mechanistic hypotheses within the discovery workflow.
What do quantitative AmFRET measurements enable in R&D?
Quantitative AmFRET outputs provide single-cell resolution data on assembly states, enabling comparative analysis of variants, detection of nucleation barriers, and robust decision-making for target advancement.
Why are replication requirements critical for DAmFRET cross-functional collaboration?
Replication ensures that DAmFRET results are reproducible across teams and platforms, supporting cross-functional confidence in assay outputs and facilitating enterprise-wide adoption for target evaluation.
What statistical analysis capabilities are required before DAmFRET implementation?
Robust statistical tools are needed to analyze FRET distributions, set compensation, and distinguish true assembly events from background, ensuring reliable interpretation and actionable insights for R&D teams.
Chapters in this video
0:04
Title
0:56
Saccharomyces cerevisiae Preparation
2:04
Photoconversion and Distributed Amphifluoric Fluorescence Resonance Energy Transfer (DAmFRET) Data Collection
2:51
Data Analysis
3:32
Results: Representative In Vivo Protein Self-Assembly Detection and Characterization
5:26
Conclusion
